Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine

Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine

First-line chemotherapy has been established for advanced biliary tract cancer (BTC). However, few treatment options are available as second-line treatment. Advances in comprehensive genomic analysis revealed that nearly half of patients with BTC harbor targetable genetic alterations such as fibrobl...

Full description

Bibliographic Details
Main Authors: Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, Takaaki Furukawa, Tsuyoshi Takeda, Akiyoshi Kasuga, Masato Ozaka, Naoki Sasahira
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Cancers
Subjects:
cholangiocarcinoma
biliary tract cancer
targeted therapy
precision medicine
Online Access:https://www.mdpi.com/2072-6694/16/5/879

Similar Items

Similar Items